Site icon Market Globalist

What Is Driving Asensus Surgical (TRXC) Stock Up Today?

Shares of the medical device company Asensus Surgical, Inc. (TRXC) have been surging 21.17% in early trades today rising to $4.75 at last check. The surge came on the heels of an announcement by the company regarding an FDA clearance of its general surgery.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What actually has been causing the stock rise?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Formerly known as TransEnterix, Inc., by unlocking the Clinical Intelligence within the its Surgical platform, Asensus Surgical is pioneering the delivery of consistently superior outcomes and an entirely new standard of surgery through the digitization of the interface between the surgeon and patient. A part of company’s Analytical/Surgical Robotics system is called the Intelligent Surgical Unit (ISU) which integrates the Senhance Surgical System with the ISU to reduce variability and increase surgeon control.

Read More

Announced today, Senhance Surgical System has been given FDA clearance for an additional indication which increases its indication in general surgery in the United States. Today, Asensus Surgical announced it has received this FDA clearance.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Exit mobile version